Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
Pt 6
pubmed:dateCreated
2006-5-12
pubmed:abstractText
Genetic immunization using viral vectors provides an effective means to elicit antigen-specific cellular immune responses. Several viral vectors have proven efficacious in inducing immune responses after direct injection in vivo. Among them, recombinant, self-inactivating lentiviral vectors are very attractive delivery systems, as they are able to efficiently transduce into and express foreign genes in a wide variety of mammalian cells. A self-inactivating lentiviral vector was evaluated for the delivery of human immunodeficiency virus 1 (HIV-1) envelope sequences in mice in order to elicit specific immune responses. With this aim, BALB/c mice were immunized with a single injection of self-inactivating lentiviral vectors carrying either the full-length HIV-1(HXB2) Rev/Env (TY2-IIIBEnv) or the codon-optimized HIV-1(JR-FL) gp120 (TY2-JREnv) coding sequence. Both vectors were able to elicit specific cellular responses efficiently, as measured by gamma interferon ELISPOT and chromium-release assays, upon in vitro stimulation of splenocytes from BALB/c immunized mice. However, only the TY2-JREnv-immunized mice were able to elicit specific humoral responses, measured as anti-gp120 antibody production. These data provide the first evidence that a single, direct, in vivo administration of a lentiviral vector encoding a viral gene might represent a useful strategy for vaccine development.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jun
pubmed:issn
0022-1317
pubmed:author
pubmed:issnType
Print
pubmed:volume
87
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1625-34
pubmed:dateRevised
2008-11-21
pubmed:meshHeading
pubmed-meshheading:16690927-AIDS Vaccines, pubmed-meshheading:16690927-Animals, pubmed-meshheading:16690927-Codon, pubmed-meshheading:16690927-Female, pubmed-meshheading:16690927-Gene Products, env, pubmed-meshheading:16690927-Gene Products, rev, pubmed-meshheading:16690927-Genes, env, pubmed-meshheading:16690927-Genes, rev, pubmed-meshheading:16690927-Genetic Vectors, pubmed-meshheading:16690927-HIV Antibodies, pubmed-meshheading:16690927-HIV Envelope Protein gp120, pubmed-meshheading:16690927-HIV Infections, pubmed-meshheading:16690927-HIV-1, pubmed-meshheading:16690927-Humans, pubmed-meshheading:16690927-Immunization, pubmed-meshheading:16690927-Injections, Intramuscular, pubmed-meshheading:16690927-Interferon-gamma, pubmed-meshheading:16690927-Lentivirus, pubmed-meshheading:16690927-Mice, pubmed-meshheading:16690927-Mice, Inbred BALB C, pubmed-meshheading:16690927-T-Lymphocytes, pubmed-meshheading:16690927-T-Lymphocytes, Cytotoxic, pubmed-meshheading:16690927-rev Gene Products, Human Immunodeficiency Virus
pubmed:year
2006
pubmed:articleTitle
A single administration of lentiviral vectors expressing either full-length human immunodeficiency virus 1 (HIV-1)(HXB2) Rev/Env or codon-optimized HIV-1(JR-FL) gp120 generates durable immune responses in mice.
pubmed:affiliation
National AIDS Center, Department of Drugs and Evaluation, Istituto Superiore di Sanità, Viale Regina Elena 299, 00161, Rome, Italy.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't